Developmental programming: Prenatal and postnatal contribution of androgens and insulin in the reprogramming of estradiol positive feedback disruptions in prenatal testosterone-treated sheep

Endocrinology

Volumn 153, Issue 6, 2012, Pages 2813-2822

  Salloum, Bachir Abi ^a   Herkimer, Carol ^a   Lee, James S ^a   Veiga Lopez, Almudena ^a   Padmanabhan, Vasantha ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANTIANDROGEN; ESTRADIOL; FLUTAMIDE; INSULIN; INSULIN SENSITIZING AGENT; LUTEINIZING HORMONE; ROSIGLITAZONE; TESTOSTERONE PROPIONATE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EWE; FEMALE; HORMONE ACTION; HORMONE RESPONSE; INSULIN SENSITIVITY; LUTEINIZING HORMONE RELEASE; NEUROENDOCRINOLOGY; NONHUMAN; PERINATAL PERIOD; POSITIVE FEEDBACK; PRENATAL PERIOD; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; ANDROGEN ANTAGONISTS; ANDROGENS; ANIMALS; ESTRADIOL; ESTROGENS; FEEDBACK, PHYSIOLOGICAL; FEMALE; FLUTAMIDE; HYPOGLYCEMIC AGENTS; LUTEINIZING HORMONE; MALE; PREGNANCY; SHEEP; TESTOSTERONE; THIAZOLIDINEDIONES; TIME FACTORS;

EID: 84861326656     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-2074     Document Type: Article

References (71)

1. Padmanabhan V, Sarma HN, Savabieasfahani M, Steckler TL, Veiga-Lopez A 2010 Developmental reprogramming of reproductive and metabolic dysfunction in sheep: native steroids vs. environmental steroid receptor modulators. Int J Andro 33:394-404
2. Padmanabhan V, Veiga-Lopez A 2011 Developmental origin of reproductive and metabolic dysfunctions: androgenic vs. estrogenic reprogramming. Semin Reprod Med 29:173-186
3. Sarma HN, Manikkam M, Herkimer C, Dell'Orco J, Welch KB, Foster DL, Padmanabhan V 2005 Fetal programming: excess prenatal testosterone reduces postnatal luteinizing hormone, but not follicle-stimulating hormone responsiveness, to estradiol negative feedback in the female. Endocrinology 146:4281-4291 (Pubitemid 41324024)
4. Veiga-Lopez A, Astapova OI, Aizenberg EF, Lee JS, Padmanabhan V 2009 Developmental programming: contribution of prenatal androgen and estrogen to estradiol feedback systems and periovulatory hormonal dynamics in sheep. Biol Reprod 80:718-725
5. Unsworth WP, Taylor JA, Robinson JE 2005 Prenatal programming of reproductive neuroendocrine function: the effect of prenatal androgens on the development of estrogen positive feedback and ovarian cycles in the ewe. Biol Reprod 72:619-627 (Pubitemid 40279840)
6. Sharma TP, Herkimer C, West C, Ye W, Birch R, Robinson JE, Foster DL, Padmanabhan V 2002 Fetal programming: prenatal androgen disrupts positive feedback actions of estradiol but does not affect timing of puberty in female sheep. Biol Reprod 66:924-933 (Pubitemid 34263111)
7. Robinson JE, Forsdike RA, Taylor JA 1999 In utero exposure of female lambs to testosterone reduces the sensitivity of the gonadotropin- releasing hormone neuronal network to inhibition by progesterone. Endocrinology 140:5797-5805 (Pubitemid 30645369)
8. Veiga-Lopez A, Ye W, Phillips DJ, Herkimer C, Knight PG, Padmanabhan V 2008 Developmental programming: deficits in reproductive hormone dynamics and ovulatory outcomes in prenatal, testosterone- treated sheep. Biol Reprod 78:636-647 (Pubitemid 351469343)
9. Wood RI, Foster DL 1998 Sexual differentiation of reproductive neuroendocrine function in sheep. Rev Reprod 3:130-140 (Pubitemid 28310285)
10. Jackson LM, Timmer KM, Foster DL 2008 Sexual differentiation of the external genitalia and the timing of puberty in the presence of an antiandrogen in sheep. Endocrinology 149:4200-4208
11. Masek KS, Wood RI, Foster DL 1999 Prenatal dihydrotestosterone differentially masculinizes tonic and surge modes of luteinizing hormone secretion in sheep. Endocrinology 140:3459-3466 (Pubitemid 30645401)
12. Handa RJ, Pak TR, Kudwa AE, Lund TD, Hinds L 2008 An alternate pathway for androgen regulation of brain function: activation of estrogen receptor β by the metabolite of dihydrotestosterone, 5α-androstane-3β, 17β-diol. Horm Behav 53:741-752
13. Chiu SL, Cline HT 2010 Insulin receptor signaling in the development of neuronal structure and function. Neural Dev 15:7-25
14. Desai M, Li T, Ross MG 2011 Fetal hypothalamic neuroprogenitor cell culture: preferential differentiation paths induced by leptin and insulin. Endocrinology 152:3192-3201
15. Dubois PM 1990 Ontogenesis of gonadotropic cells. Ann Endocrinol 51:47-53
16. Wood RI, Newman SW, Lehman MN, Foster DL 1992 GnRH neurons in the fetal lamb hypothalamus are similar in males and females. Neuroendocrinology 55:427-433
17. Brooks AN, Hagan DM, Sheng C, McNeilly AS, Sweeney T 1996 Prenatal gonadotrophins in the sheep. Anim Reprod Sci 42:471-481 (Pubitemid 26352246)
18. Veiga-Lopez A, Muralidharan M, Padmanabhan V, Developmental programming: gestational testosterone excess compromises fetal pancreatic differentiation. Program of 94th Annual Meeting of Endocrine Society, San Diego, 2010 (Abstract 143)
19. Cernea M, Lee T, Cheng G, Padmanabhan V, Lehman M, Coolen L, Excess prenatal testosterone increases androgen receptor expression in the female sheep brain. Program of the Annual Meeting of the Society for Neuroscience, Washington, DC, 2011 (Abstract 499.20)
20. Padmanabhan V, Veiga-Lopez A, Abbott DH, Recabarren SE, Herkimer C 2010 Developmental programming: impact of prenatal testosterone excess and postnatal weight gain on insulin sensitivity index and transfer of traits to offspring of overweight females. Endocrinology 15:595-605
21. Recabarren SE, Padmanabhan V, Codner E, Lobos A, Durán C, Vidal M, Foster DL, Sir-Petermann T 2005 Postnatal developmental consequences of altered insulin sensitivity in female sheep treated prenatally with testosterone. Am J Physiol Endocrinol Metab 289:E801-E806 (Pubitemid 41504379)
22. Brüning JC, Gautam D, Burks DJ, Gillette J, Schubert M, Orban PC, Klein R, Krone W, Müller-Wieland D, Kahn CR 2000 Role of brain insulin receptor in control of body weight and reproduction. Science 289:2122-2125
23. Burks DJ, Font de Mora J, Schubert M, Withers DJ, Myers MG, Towery HH, Altamuro SL, Flint CL, White MF 2000 IRS-2 pathways integrate female reproduction and energy homeostasis. Nature 407:377-382
24. Gamba M, Pralong FP 2006 Control of GnRH neuronal activity by metabolic factors: the role of leptin and insulin. Mol Cell Endocrinol 254-255:133-139 (Pubitemid 44063601)
25. Steger RW, Kienast SG, Pillai S, Rabe M 1993 Effects of streptozo- tocin-induced diabetes on neuroendocrine responses to ovariectomy and estrogen replacement in female rats. Neuroendocrinology 57:525-531 (Pubitemid 23170159)
26. Veiga-Lopez A, Lee JS, Padmanabhan V 2010 Developmental programming: insulin sensitizer treatment improves reproductive function in prenatal testosterone-treated female sheep. Endocrinology 151:4007-4017
27. Legro RS, Zaino RJ, Demers LM, Kunselman AR, Gnatuk CL, Williams NI, Dodson WC 2007 The effects of metformin and rosiglitazone, alone and in combination, on the ovary and endometrium in polycystic ovary syndrome. Am J Obstet Gynecol 196:402.e10-402.e11
28. Roy KK, Baruah J, Sharma A, Sharma JB, Kumar S, Kachava G, Karmakar D 2010 A prospective randomized trial comparing the clinical and endocrinological outcome with rosiglitazone versus laparoscopic ovarian drilling in patients with polycystic ovarian disease resistant to ovulation induction with clomiphene citrate. Arch Gynecol Obstet 281:939-944
29. Foster DL 1984 Preovulatory gonadotropin surge system of prepubertal female sheep is exquisitely sensitive to the stimulatory feedback action of estradiol. Endocrinology 115:1186-1189 (Pubitemid 14074493)
30. Niswender GD, Reichert Jr LE, Midgley Jr AR, Nalbandov AV 1969 Radioimmunoassay for bovine and ovine luteinizing hormone. Endocrinology 84:1166-1173
31. Veiga-Lopez A, Steckler TL, Abbott DH, Welch KB, MohanKumar PS, Phillips DJ, Refsal K, Padmanabhan V 2011 Developmental programming: impact of excess prenatal testosterone on intrauterine fetal endocrine milieu and growth in sheep. Biol Reprod 84:87-96
32. Pak TR, Chung WC, Lund TD, Hinds LR, Clay CM, Handa RJ 2005 The androgen metabolite, 5-androstane-3,17-diol, is a potent modulator of estrogen receptor-1-mediated gene transcription in neuronal cells. Endocrinology 146:147-155 (Pubitemid 40051734)
33. Schaub CE, Gersting JA, Keller-Wood M, Wood CE 2008 Development of ER-α and ER-β expression in the developing ovine brain and pituitary. Gene Expr Patterns 8:457-463
34. Wintermantel TM, Campbell RE, Porteous R, Bock D, Gröne HJ, Todman MG, Korach KS, Greiner E, Pérez CA, Schütz G, Herbison AE 2006 Definition of estrogen receptor pathway critical for estrogen positive feedback to gonadotropin-releasing hormone neurons and fertility. Neuron 52:271-280 (Pubitemid 44548337)
35. Jayes FL, Rodriguez KF, Couse JF, Yates MM, Korach KS 2008 Estrogen receptor-β action in the ovary, but not in the hypothalamic- pituitary axis, is required for the generation of normal luteinizing hormone surges in mice. Biol Reprod 78:52 (Abstract)
36. Herman RA, Jones B, Mann DR, Wallen K 2000 Timing of prenatal androgen exposure: anatomical and endocrine effects on juvenile male and female rhesus monkeys. Horm Behav 38:52-66 (Pubitemid 30626783)
37. Place NJ, Holekamp KE, Sisk CL, Weldele ML, Coscia EM, Drea CM, Glickman SE 2002 Effects of prenatal treatment with antiandrogens on luteinizing hormone secretion and sex steroid concentrations in adult spotted hyenas, Crocuta crocuta. Biol Reprod 67:1405-1413 (Pubitemid 35204915)
38. Savabieasfahani M, Kannan K, Astapova O, Evans NP, Padmanabhan V 2006 Developmental programming: differential effects of prenatal exposure to bisphenol-A or methoxychlor on reproductive function. Endocrinology 147:5956-5966 (Pubitemid 44833514)
39. Vandenberg LN, Maffini MV, Sonnenschein C, Rubin BS, Soto AM 2009 Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr Rev 30:75-95
40. Padmanabhan V, Manikkam M, Recabarren S, Foster D 2006 Prenatal testosterone excess programs reproductive and metabolic dysfunction in the female. Mol Cell Endocrinol 246:165-174 (Pubitemid 43238412)
41. Eagleson CA, Gingrich MB, Pastor CL, Arora TK, Burt CM, Evans WS, Marshall JC 2000 Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. J Clin Endocrinol Metab 85:4047-4052 (Pubitemid 32055351)
42. Downing JA, Scaramuzzi RJ 1997 The effect of the infusion of insulin during the luteal phase of the estrous cycle on the ovulation rate and on plasma concentrations of LH, FSH and glucose in ewes. Theriogenology 47:747-759 (Pubitemid 28137106)
43. Adam CL, Findlay PA, Chanet A, Aitken RP, Milne JS, Wallace JM 2008 Expression of energy balance regulatory genes in the developing ovine fetal hypothalamus at midgestation and the influence of hyperglycemia. Am J Physiol Regul Integr Comp Physiol 294:R1895-R1900
44. Herbosa CG, Dahl GE, Evans NP, Pelt J, Wood RI, Foster DL 1996 Sexual differentiation of the surge mode of gonadotropin secretion: prenatal androgens abolish the gonadotropin-releasing hormone surge in the sheep. J Neuroendocrinol 8:627-633 (Pubitemid 26270916)
45. Buggs C, Weinberg F, Kim E, Wolfe A, Radovick S, Wondisford F 2006 Insulin augments GnRH-stimulated LHβ gene expression by Egr-1. Mol Cell Endocrinol 249:99-106
46. Manikkam M, Thompson RC, Herkimer C, Welch KB, Flak J, Karsch FJ, Padmanabhan V 2008 Developmental programming: impact of prenatal testosterone excess on pre- and postnatal gonadotropin regulation in sheep. Biol Reprod 78:648-660 (Pubitemid 351469344)
47. Steckler TL, Herkimer C, Dumesic DA, Padmanabhan V 2009 Developmental programming: excess weight gain amplifies the effects of prenatal testosterone excess on reproductive cyclicity - implication for polycystic ovary syndrome. Endocrinology 150:1456-1465
48. Padmanabhan V, Veiga-Lopez A, Abbott DH, Dumesic DA 2007 Developmental programming of ovarian disruption. In: Gonzalez- Bulnes, ed. Novel concepts in ovarian endocrinology. Kerala, India: India Research Signpost; 329-352
49. Velazquez EM, Mendoza S, Hamer T, Sosa F, Glueck CJ 1994 Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism 43:647-654 (Pubitemid 24145474)
50. Belli SH, Graffigna MN, Oneto A, Otero P, Schurman L, Levalle OA 2004 Effect of rosiglitazone on insulin resistance, growth factors, and reproductive disturbances in women with polycystic ovary syndrome. Fertil Steril 81:624-629 (Pubitemid 38376120)
51. Genazzani AD, Battaglia C, Malavasi B, Strucchi C, Tortolani F, Gamba O 2004 Metformin administration modulates and restores luteinizing hormone spontaneous episodic secretion and ovarian function in nonobese patients with polycystic ovary syndrome. Fertil Steril 81:114-119 (Pubitemid 38058335)
52. Genazzani AD, Strucchi C, Luisi M, Casarosa E, Lanzoni C, Baraldi E, Ricchieri F, Mehmeti H, Genazzani AR 2006 Metformin administration modulates neurosteroids secretion in non-obese amenorrhoic patients with polycystic ovary syndrome. Gynecol Endocrinol 22:36-43 (Pubitemid 43355096)
53. Mehta RV, Patel KS, Coffler MS, Dahan MH, Yoo RY, Archer JS, Malcom PJ, Chang RJ 2005 Luteinizing hormone secretion is not influenced by insulin infusion in women with polycystic ovary syndrome despite improved insulin sensitivity during pioglitazone treatment. J Clin Endocrinol Metab 90:2136-2141 (Pubitemid 40586252)
54. Roland AV, Moenter SM 2011 Prenatal androgenization of female mice programs an increase in firing activity of gonadotropin-releasing hormone (GnRH) neurons that is reversed by metformin treatment in adulthood. Endocrinology 152:618-628
55. Heald M, Cawthorne MA 2011 Dual acting and pan-PPAR activators as potential anti-diabetic therapies. Handb Exp Pharmacol 203:35-51
56. Klotz L 2008 Maximal androgen blockade for advanced prostate cancer. Best Pract Res Clin Endocrinol Metab 22:331-340 (Pubitemid 351611950)
57. Malcolm KD, Jackson LM, Bergeon C, Lee TM, Padmanabhan V, Foster DL 2006 Long-term exposure of female sheep to physiologic concentrations of estradiol: effects on the onset and maintenance of reproductive function, pregnancy, and social development in female offspring. Biol Reprod 75:844-852 (Pubitemid 44845589)
58. Goodman RL 1994 Neuroendocrine control of the ovine estrous cycle. In: Knobil E, Neill JD, eds. The physiology of reproduction. 2nd ed. Vol 2. New York: Raven Press; 659-709
59. Gilchrist RB 2010 Recent insights into oocyte-follicle cell interactions provide opportunities for the development of new approaches to in vitro maturation. Repro Fert Develop 23:23-31
60. Eppig JJ 1996 Coordination of nuclear and cytoplasmic oocyte maturation in eutherian mammals. Reprod Fertil Dev 8:485-489 (Pubitemid 26288024)
61. Freeman ME, Butcher RL, Fugo NW 1970 Alteration of oocytes and follicles by delayed ovulation. Biol Reprod 2:209-215
62. Carriere PD, Kohram H, Price CA, Durocher J, Guilbault LA 2002 Effects of delaying the LH surge and altering LH secretion on plasma hormones and embryo production in heifers superstimulated with FSH. Can J Anim Sci 82:357-366 (Pubitemid 35409671)
63. De Leo V, Lanzetta D, D'Antona D, la Marca A, Morgante G 1998 Hormonal effects of flutamide in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 83:99-102 (Pubitemid 28498317)
64. Nestler JE, Jakubowicz DJ, Evans WS, Pasquali R 1998 Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Eng J Med 338:1876-1880 (Pubitemid 28287859)
65. Palomba S, Falbo A, Zullo F, Orio Jr F 2009 Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review. Endocr Rev 30:1-50
66. Legro RS, Barnhart HX, Schlaff WD, Carr BR, Diamond MP, Carson SA, Steinkampf MP, Coutifaris C, McGovern PG, Cataldo NA, Gosman GG, Nestler JE, Giudice LC, Leppert PC, Myers for the Cooperative Multicenter Reproductive Medicine Network 2007 Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Eng J Med 356:551-566
67. Tang T, Lord JM, Norman RJ, Yasmin E, Balen AH 2010 Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiroinositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev 3:CD003053
68. Ajossa S, Guerriero S, Paoletti AM, Orrù M, Melis GB 2004 The treatment of polycystic ovary syndrome. Minerva Ginecol 56:15-26 (Pubitemid 38313778)
69. Ibáñez L, Valls C, Ferrer A, Ong K, Dunger DB, De Zegher F 2002 Additive effects of insulin-sensitizing and anti-androgen treatment in young, nonobese women with hyperinsulinism, hyperandrogenism, dyslipidemia, and anovulation. J Clin Endocrinol Metab 87:2870-2874 (Pubitemid 34655356)
70. Steckler T, Manikkam M, Inskeep EK, Padmanabhan V 2007 Developmental programming: follicular persistence in prenatal testosterone- treated sheep is not programmed by androgenic actions of testosterone. Endocrinology 148:3532-3540 (Pubitemid 46997017)
71. Manikkam M, Steckler TL, Welch KB, Inskeep EK, Padmanabhan V 2006 Fetal programming: prenatal testosterone treatment leads to follicular persistence/luteal defects; partial restoration of ovarian function by cyclic progesterone treatment. Endocrinology 147:1997-2007